Companies / Indonesia
Bird Flu Vaccine MOU Signed With Baxter
February 2007 | Project NewsIndonesia has signed a memorandum of understanding (MOU) with US firm Baxter International to develop a vaccine against avian influenza. Simultaneously, the country has revealed that it has stopped sharing H5N1 bird flu virus samples with foreign laboratories, leading to intense criticism from virologists and public health officials, who believe Indonesia's actions will accelerate the onset and increase the magnitude of a bird flu pandemic. BMI is deeply concerned at the country's stance, which is motivated by maintenance of intellectual property rights. In effect, Indonesia is trying to secure an affordable supply of bird flu vaccine by holding the world
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
